Skip to content
Clinical Trials – home
Research site

Universita' Politecnica Delle Marche

Italy Via Conca 71, 60126 Ancona, Italy

  • 124 trials recruiting
  • Plasma cell myeloma · Breast cancer · Hidradenitis
  • Adults and children

About Specializations

Universita' Politecnica Delle Marche in Ancona, Italy specialises in clinical trials of conditions such as Plasma cell myeloma, Breast cancer, Hidradenitis, Dermatitis atopic, and other specialisations. This site conducts important research.

Main research areas of the site

Immune System Diseases and Musculoskeletal Diseases

At Universita' Politecnica Delle Marche, clinical research in this area focuses on the overlap between immune system disorders and muscle-related conditions, with particular attention to polymyositis and dermatomyositis. The studies are designed to better understand disease activity and assess whether new treatment approaches can improve patient outcomes.

  • Exploring treatment options for idiopathic inflammatory myopathies
  • Evaluating the impact of anifrolumab compared with placebo alongside standard care
  • Assessing improvement in disease activity for adults with polymyositis and dermatomyositis

This work reflects a focused effort in clinical immunology and rheumatology, aiming to support more effective care for people living with these rare inflammatory diseases.

Immune System Phenomena and Musculoskeletal and Neural Physiological Phenomena

The research portfolio also examines key immune system processes and their effects on muscle function and related physiological changes. Conducted at the Department of Molecular and Clinical Sciences, these trials contribute to a better understanding of how inflammation influences disease progression and treatment response.

  • Studying immune-mediated inflammation in inflammatory myopathies
  • Investigating how therapy may improve musculoskeletal symptoms
  • Supporting research into more precise disease control for affected adults

With a small but targeted trial base and broad investigator involvement, the site is building knowledge around autoimmune muscle disease and practical ways to measure treatment benefit.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Via Conca 7160126 AnconaItaly
Recruiting now
124 trials
Conditions studied
174

More sites in AnconaItaly

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

305 clinical trials

Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Topotecan Hydrochloride
  • Sponsor:Zai Lab (US) LLC

Renal disorder

Recruiting
Investigational
Countries:ItalyItaly
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:[4-(6-Aminopyridazin-3-Yl)Piperidin-1-Yl][5-(4-Fluorophenoxy)-4-Methoxypyridin-2-Yl]Methanone
  • Sponsor:Boehringer Ingelheim Espana S.A.
Investigational
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Zasocitinib
  • Sponsor:Takeda Development Center Americas Inc.
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Barzolvolimab
  • Sponsor:Celldex Therapeutics Inc.
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Sponsor:Sanofi-Aventis Recherche & Developpement
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:BioNTech SE
Countries:ItalyItaly
  • Participants:18–64 years
  • Substances:Trospium Chloride
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Trospium Chloride
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Povorcitinib
  • Sponsor:Incyte Corp.
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Bi 690517
  • Sponsor:Boehringer Ingelheim Espana S.A.

Bronchiectasis

Recruiting
Investigational
Countries:ItalyItaly
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Bi 1291583
  • Sponsor:Boehringer Ingelheim Espana S.A.
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Docetaxel
  • Sponsor:Daiichi Sankyo Inc.
Is this your site?

Join our network of research sites

Get verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.